Dr Reddy's 实验室:美国 FDA 授予一年两次注射型 Lenacapavir 临时批准

投资观察
Nov 02

11月2日——Dr. Reddy's Laboratories Limited 宣布:*美国 FDA 已对 Dr. Reddy's 研发的一年两次注射型 Lenacapavir 授予临时批准。*该注射型 Lenacapavir 将以每人每年 40 美元的价格,在吉利德科学自愿许可所覆盖的 120 个国家上市。*首批注射型 Lenacapavir 供应预计将在 2026 年底之前到位,2027 年将在符合条件的国家实现更广泛的供应。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10